Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Elluru, Sri Ramulu ^a,b,c,d   van Huyen, Jean Paul Duong ^a,b,c,e   Delignat, Sandrine ^a,b,c   Kazatchkine, Michel D ^a,b,c   Friboulet, Alain ^d   Kaveri, Srini V ^a,b,c   Bayry, Jagadeesh ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE TECHNOLOGIE DE COMPIÈGNE   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 18; INTERLEUKIN 6; MELANOMA ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; VA QU SPEZ; VISCUM ALBUM EXTRACT; CD86 PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 8; MELAN A; MLANA PROTEIN, HUMAN; PLANT EXTRACT; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; CANCER REGRESSION; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; MIXED LYMPHOCYTE REACTION; MONOCYTE; SUPERNATANT; T LYMPHOCYTE; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; CHEMISTRY; CLONAL ANERGY; DRUG EFFECT; IMMUNOLOGY; METHODOLOGY; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; PHYTOTHERAPY; VISCUM ALBUM;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, NEOPLASM; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CLONAL ANERGY; DENDRITIC CELLS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MART-1 ANTIGEN; NEOPLASM PROTEINS; PHYTOTHERAPY; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA; VISCUM ALBUM;

EID: 47349093062     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-161     Document Type: Article

References (37)

1. Olsnes S Stirpe F Sandvig K Pihl A Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe) J Biol Chem 1982, 257(22):13263-13270. 7142144
2. Khwaja TA Dias CB Pentecost S Recent studies on the anticancer activities of mistletoe (Viscum album) and its alkaloids Oncology 1986, 43(Suppl 1):42-50. 3543783
3. Franz H Ziska P Kindt A Isolation and properties of three lectins from mistletoe (Viscum album L.) Biochem J 1981, 195(2):481-484. 1162912 7316963
4. Urech K Schaller G Jaggy C Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador Arzneimittelforschung 2006, 56(6A):428-434. 16927522
5. Klopp R Schmidt W Werner E Werner M Niemer W Beuth J Influence of complementary Viscum album (Iscador) administration on microcirculation and immune system of ear, nose and throat carcinoma patients treated with radiation and chemotherapy Anticancer Res 2005, 25(1B):601-610. 15816634
6. Augustin M Bock PR Hanisch J Karasmann M Schneider B Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and Switzerland Arzneimittelforschung 2005, 55(1):38-49. 15727163
7. Braun JM Ko HL Schierholz JM Beuth J Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models Anticancer Res 2002, 22(6C):4187-4190. 12553054
8. Park WB Lyu SY Kim JH Choi SH Chung HK Ahn SH Hong SY Yoon TJ Choi MJ Inhibition of tumor growth and metastasis by Korean mistletoe lectin is associated with apoptosis and antiangiogenesis Cancer Biother Radiopharm 2001, 16(5):439-447. 10.1089/108497801753354348 11776761
9. Bussing A Schietzel M Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins Anticancer Res 1999, 19(1A):23-28. 10226520
10. Stein GM Pfuller U Schietzel M Bussing A Toxic proteins from European mistletoe (Viscum album L.): Increase of intracellular IL-4 but decrease of IFN-gamma in apoptotic cells Anticancer Res 2000, 20(3A):1673-1678. 10928090
11. Stein GM Pfuller U Schietzel M Bussing A Expression of interleukin-4 in apoptotic cells: Stimulation of the type-2 cytokine by different toxins in human peripheral blood mononuclear and tumor cells Cytometry 2000, 41(4):261-270. 10.1002/ 1097-0320(20001201)41:4<261::AID-CYTO4>3.0.CO;2-S 11084611
12. Stein GM Pfuller U Schietzel M Bussing A Intracellular expression of IL-4 and inhibition of IFN-gamma by extracts from European mistletoe is related to induction of apoptosis Anticancer Res 2000, 20(5A):2987-2994. 11062712
13. Duong Van Huyen JP Delignat S Bayry J Kazatchkine MD Bruneval P Nicoletti A Kaveri SV Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma Cancer Lett 2006, 243(1):32-37. 10.1016/j.canlet.2005.11.016 16412563
14. Elluru S Van Huyen JP Delignat S Prost F Bayry J Kazatchkine MD Kaveri SV Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador Arzneimittelforschung 2006, 56(6A):461-466. 16927527
15. Drake CG Jaffee E Pardoll DM Mechanisms of immune evasion by tumors Adv Immunol 2006, 90:51-81. 16730261
16. Banchereau J Steinman RM Dendritic cells and the control of immunity Nature 1998, 392(6673):245-252. 10.1038/32588 9521319
17. Banchereau J Briere F Caux C Davoust J Lebecque S Liu YJ Pulendran B Palucka K Immunobiology of dendritic cells Annu Rev Immunol 2000, 18:767-811. 10.1146/annurev.immunol.18.1.767 10837075
18. Cella M Sallusto F Lanzavecchia A Origin, maturation and antigen presenting function of dendritic cells Curr Opin Immunol 1997, 9(1):10-16. 10.1016/S0952-7915(97)80153-7 9039784
19. Steinman RM Inaba K Turley S Pierre P Mellman I Antigen capture, processing, and presentation by dendritic cells: Recent cell biological studies Hum Immunol 1999, 60(7):562-567. 10.1016/S0198-8859(99)00030-0 10426272
20. Inaba K Turley S Yamaide F Iyoda T Mahnke K Inaba M Pack M Subklewe M Sauter B Sheff D Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells J Exp Med 1998, 188(11):2163-2173. 2212389 9841929 10.1084/jem.188.11.2163
21. Rabinovich GA Gabrilovich D Sotomayor EM Immunosuppressive strategies that are mediated by tumor cells Annu Rev Immunol 2007, 25:267-296. 10.1146/annurev.immunol.25.022106.141609 17134371
22. Wang Z Cao Y Albino AP Zeff RA Houghton A Ferrone S Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA J Clin Invest 1993, 91(2):684-692. 288010 8432869 10.1172/JCI116249
23. Natali PG Nicotra MR Bigotti A Venturo I Marcenaro L Giacomini P Russo C Selective changes in expression of HLA class I polymorphic determinants in human solid tumors Proc Natl Acad Sci USA 1989, 86(17):6719-6723. 297917 2672003 10.1073/pnas.86.17.6719
24. Hicklin DJ Marincola FM Ferrone S HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story Mol Med Today 1999, 5(4):178-186. 10.1016/S1357-4310(99)01451-3 10203751
25. Rivoltini L Carrabba M Huber V Castelli C Novellino L Dalerba P Mortarini R Arancia G Anichini A Fais S et al. Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction Immunol Rev 2002, 188:97-113. 10.1034/j.1600-065X.2002.18809.x 12445284
26. Parmiani G Sensi M Castelli C Rivoltini L Anichini A T-cell response to unique and shared antigens and vaccination of cancer patients Cancer Immun 2002, 2:6. 12747751
27. Steinbrink K Wolfl M Jonuleit H Knop J Enk AH Induction of tolerance by IL-10-treated dendritic cells J Immunol 1997, 159(10):4772-4780. 9366401
28. Gervois N Guilloux Y Diez E Jotereau F Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions J Exp Med 1996, 183(5):2403-2407. 2192543 8642353 10.1084/jem.183.5.2403
29. Guilloux Y Lucas S Brichard VG Van Pel A Viret C De Plaen E Brasseur F Lethe B Jotereau F Boon T A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene J Exp Med 1996, 183(3):1173-1183. 2192325 8642259 10.1084/jem.183.3.1173
30. Kichler-Lakomy C Budinsky AC Wolfram R Hellan M Wiltschke C Brodowicz T Viernstein H Zielinski CC Deficiences in phenotype expression and function of dentritic cells from patients with early breast cancer Eur J Med Res 2006, 11(1):7-12. 16504954
31. Wolfram RM Budinsky AC Brodowicz T Kubista M Kostler WJ Kichler-Lakomy C Hellan M Kahlhammer G Wiltschke C Zielinski CC Defective antigen presentation resulting from impaired expression of costimulatory molecules in breast cancer Int J Cancer 2000, 88(2):239-244. 10.1002/ 1097-0215(20001015)88:2<239::AID-IJC15>3.0.CO;2-Z 11004675
32. Heinzerling L von Baehr V Liebenthal C von Baehr R Volk HD Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo J Clin Immunol 2006, 26(4):347-359. 10.1007/s10875-006-9023-5 16705487
33. Stein GM Bussing A Schietzel M Stimulation of the maturation of dendritic cells in vitro by a fermented mistletoe extract Anticancer Res 2002, 22(6C):4215-4219. 12553059
34. Stein GM Bussing A Schietzel M Activation of dendritic cells by an aqueous mistletoe extract and mistletoe lectin-3 in vitro Anticancer Res 2002, 22(1A):267-274. 12017301
35. Hostanska K Hajto T Spagnoli GC Fischer J Lentzen H Herrmann R A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells Nat Immun 1995, 14(5-6):295-304. 8933823
36. Curti A Isidori A Ferri E Terragna C Neyroz P Cellini C Ratta M Baccarani M Lemoli RM Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy Leuk Lymphoma 2004, 45(7):1419-1428. 10.1080/10428190310001653682 15359643
37. Tsai JP Chen HW Cheng ML Liu HK Lee YP Hsieh CL Luh KT Wu CW Hsu LH Chao TY Analysis of host versus tumor interaction in cancer patients: opposing role of transforming growth factor-beta1 and interleukin-6 in the development of in situ tumor immunity Immunobiology 2005, 210(9):661-671. 10.1016/j.imbio.2005.07.004 16323703